US Stock MarketDetailed Quotes

Apellis Pharmaceuticals (APLS)

Watchlist
  • 41.030
  • 0.0000.00%
Trading May 13 16:00 ET
5.25BMarket Cap38.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apellis Pharmaceuticals (APLS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
60.85%268.3M
28.46%1B
-5.94%199.91M
132.98%458.58M
-10.61%178.49M
-3.21%166.8M
97.02%781.37M
45.19%212.53M
78.29%196.83M
110.26%199.69M
Operating revenue
60.85%268.3M
28.46%1B
-5.94%199.91M
132.98%458.58M
-10.61%178.49M
-3.21%166.8M
97.02%781.37M
45.19%212.53M
78.29%196.83M
110.26%199.69M
Cost of revenue
18.01%40.55M
-13.16%102.24M
-27.26%29.72M
-26.90%24.53M
-41.01%13.63M
70.02%34.36M
101.20%117.72M
105.18%40.86M
49.74%33.56M
175.69%23.1M
Gross profit
71.97%227.75M
35.85%901.55M
-0.86%170.19M
165.84%434.05M
-6.64%164.87M
-12.94%132.44M
96.30%663.64M
35.75%171.67M
85.56%163.27M
103.93%176.59M
Operating expense
-6.71%201.28M
2.11%846.12M
11.88%221.34M
0.15%210.86M
-3.82%198.15M
0.73%215.77M
-3.11%828.62M
-6.23%197.84M
-6.45%210.55M
-0.48%206.03M
Selling and administrative expenses
-3.88%124.32M
9.82%550.27M
21.09%147.1M
16.96%142.68M
2.39%131.14M
-0.12%129.35M
0.05%501.05M
-14.27%121.48M
-16.25%121.98M
15.00%128.08M
Research and development costs
-10.95%76.96M
-9.68%295.85M
-2.78%74.23M
-23.01%68.19M
-14.02%67.02M
2.03%86.42M
-7.57%327.57M
10.21%76.35M
11.52%88.57M
-18.51%77.95M
Operating profit
131.76%26.47M
133.60%55.43M
-95.47%-51.14M
572.05%223.18M
-13.05%-33.29M
-34.21%-83.33M
68.10%-164.98M
69.04%-26.16M
65.51%-47.28M
75.55%-29.44M
Net non-operating interest income expense
11.77%-7.4M
-12.91%-31.18M
9.74%-7.35M
28.41%-6.9M
-38.38%-8.55M
-129.01%-8.39M
-219.36%-27.62M
-185.14%-8.14M
-315.47%-9.64M
-361.17%-6.18M
Non-operating interest income
9.63%2.91M
2.90%13.14M
3.12%3.5M
51.47%4.38M
-18.12%2.61M
-19.53%2.66M
-38.98%12.77M
-25.33%3.4M
-42.09%2.89M
-46.95%3.18M
Non-operating interest expense
-6.63%10.32M
9.74%44.33M
-5.96%10.85M
-10.00%11.28M
19.16%11.15M
58.59%11.05M
36.54%40.39M
55.82%11.53M
71.44%12.53M
27.49%9.36M
Other net income (expense)
153.33%88K
96.77%-133K
91.44%-151K
-47.14%37K
107.58%146K
66.93%-165K
-466.57%-4.12M
-905.94%-1.77M
111.61%70K
-2,955.56%-1.93M
Special income (charges)
----
--0
--0
--0
--0
----
---1.95M
--0
--0
---1.95M
-Less:Other special charges
----
----
----
----
----
----
--1.95M
--0
----
--1.95M
Other non- operating income (expenses)
153.33%88K
93.87%-133K
91.44%-151K
-47.14%37K
508.33%146K
66.93%-165K
-198.49%-2.17M
-905.94%-1.77M
111.61%70K
138.10%24K
Income before tax
120.84%19.15M
112.26%24.11M
-62.58%-58.64M
480.48%216.32M
-11.03%-41.69M
-38.69%-91.88M
62.64%-196.72M
58.62%-36.07M
59.39%-56.85M
69.19%-37.54M
Income tax
45.45%496K
48.19%1.72M
9.44%313K
1.69%602K
308.77%466K
100.59%341K
-45.50%1.16M
-79.90%286K
154.08%592K
-41.24%114K
Net income
120.23%18.66M
111.31%22.39M
-62.16%-58.95M
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
Net income continuous Operations
120.23%18.66M
111.31%22.39M
-62.16%-58.95M
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
Minority interest income
Net income attributable to the parent company
120.23%18.66M
111.31%22.39M
-62.16%-58.95M
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
120.23%18.66M
111.31%22.39M
-62.16%-58.95M
475.52%215.72M
-11.93%-42.15M
-38.84%-92.23M
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
Basic earnings per share
120.27%0.15
111.25%0.18
-62.07%-0.47
471.74%1.71
-10.00%-0.33
-37.04%-0.74
64.04%-1.6
60.27%-0.29
60.68%-0.46
70.59%-0.3
Diluted earnings per share
120.27%0.15
111.25%0.18
-62.07%-0.47
463.04%1.67
-10.00%-0.33
-37.04%-0.74
64.04%-1.6
60.27%-0.29
60.68%-0.46
70.59%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 60.85%268.3M28.46%1B-5.94%199.91M132.98%458.58M-10.61%178.49M-3.21%166.8M97.02%781.37M45.19%212.53M78.29%196.83M110.26%199.69M
Operating revenue 60.85%268.3M28.46%1B-5.94%199.91M132.98%458.58M-10.61%178.49M-3.21%166.8M97.02%781.37M45.19%212.53M78.29%196.83M110.26%199.69M
Cost of revenue 18.01%40.55M-13.16%102.24M-27.26%29.72M-26.90%24.53M-41.01%13.63M70.02%34.36M101.20%117.72M105.18%40.86M49.74%33.56M175.69%23.1M
Gross profit 71.97%227.75M35.85%901.55M-0.86%170.19M165.84%434.05M-6.64%164.87M-12.94%132.44M96.30%663.64M35.75%171.67M85.56%163.27M103.93%176.59M
Operating expense -6.71%201.28M2.11%846.12M11.88%221.34M0.15%210.86M-3.82%198.15M0.73%215.77M-3.11%828.62M-6.23%197.84M-6.45%210.55M-0.48%206.03M
Selling and administrative expenses -3.88%124.32M9.82%550.27M21.09%147.1M16.96%142.68M2.39%131.14M-0.12%129.35M0.05%501.05M-14.27%121.48M-16.25%121.98M15.00%128.08M
Research and development costs -10.95%76.96M-9.68%295.85M-2.78%74.23M-23.01%68.19M-14.02%67.02M2.03%86.42M-7.57%327.57M10.21%76.35M11.52%88.57M-18.51%77.95M
Operating profit 131.76%26.47M133.60%55.43M-95.47%-51.14M572.05%223.18M-13.05%-33.29M-34.21%-83.33M68.10%-164.98M69.04%-26.16M65.51%-47.28M75.55%-29.44M
Net non-operating interest income expense 11.77%-7.4M-12.91%-31.18M9.74%-7.35M28.41%-6.9M-38.38%-8.55M-129.01%-8.39M-219.36%-27.62M-185.14%-8.14M-315.47%-9.64M-361.17%-6.18M
Non-operating interest income 9.63%2.91M2.90%13.14M3.12%3.5M51.47%4.38M-18.12%2.61M-19.53%2.66M-38.98%12.77M-25.33%3.4M-42.09%2.89M-46.95%3.18M
Non-operating interest expense -6.63%10.32M9.74%44.33M-5.96%10.85M-10.00%11.28M19.16%11.15M58.59%11.05M36.54%40.39M55.82%11.53M71.44%12.53M27.49%9.36M
Other net income (expense) 153.33%88K96.77%-133K91.44%-151K-47.14%37K107.58%146K66.93%-165K-466.57%-4.12M-905.94%-1.77M111.61%70K-2,955.56%-1.93M
Special income (charges) ------0--0--0--0-------1.95M--0--0---1.95M
-Less:Other special charges --------------------------1.95M--0------1.95M
Other non- operating income (expenses) 153.33%88K93.87%-133K91.44%-151K-47.14%37K508.33%146K66.93%-165K-198.49%-2.17M-905.94%-1.77M111.61%70K138.10%24K
Income before tax 120.84%19.15M112.26%24.11M-62.58%-58.64M480.48%216.32M-11.03%-41.69M-38.69%-91.88M62.64%-196.72M58.62%-36.07M59.39%-56.85M69.19%-37.54M
Income tax 45.45%496K48.19%1.72M9.44%313K1.69%602K308.77%466K100.59%341K-45.50%1.16M-79.90%286K154.08%592K-41.24%114K
Net income 120.23%18.66M111.31%22.39M-62.16%-58.95M475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M
Net income continuous Operations 120.23%18.66M111.31%22.39M-62.16%-58.95M475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M
Minority interest income
Net income attributable to the parent company 120.23%18.66M111.31%22.39M-62.16%-58.95M475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 120.23%18.66M111.31%22.39M-62.16%-58.95M475.52%215.72M-11.93%-42.15M-38.84%-92.23M62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M
Basic earnings per share 120.27%0.15111.25%0.18-62.07%-0.47471.74%1.71-10.00%-0.33-37.04%-0.7464.04%-1.660.27%-0.2960.68%-0.4670.59%-0.3
Diluted earnings per share 120.27%0.15111.25%0.18-62.07%-0.47463.04%1.67-10.00%-0.33-37.04%-0.7464.04%-1.660.27%-0.2960.68%-0.4670.59%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +13.45%
Sample Name
Sample Code
 +10.12%
Sample Name
Sample Code
 +7.99%
4
ProShares Ultra Energy
DIG
+7.82%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+5.92%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +7.72%
Sample Name
Sample Code
 +6.72%
Sample Name
Sample Code
 +6.03%
4
Tencent Music
TME
+5.73%
5
United Microelectronics
UMC
+5.70%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -